Visual abstract | Key updates to the classification of MPN in the 5th WHO Classification of Haematolymphoid Tumours

Visual abstract | ROP-ET: Ropeginterferon alfa-2b for ET with limited treatment options

Here we summarize the study design and endpoints of the phase III ROP-ET clinical trial of ropeginterferon...

Artificial intelligence: A machine learning model for disease assessment in MPN

Here, we summarize a machine learning-based tool that fingerprints megakaryocytes for the identification,...

Visual abstract | Neonatal and maternal outcomes in pregnant women with MPN: A population-based Swedish study

Here, we present a visual abstract representing the key findings from a large...

Visual abstract | MANIFEST trial: Updates from the EHA 2022 Congress

During the European Hematology Association (EHA) 2022 Congress, Claire Harrison presented the latest results from the ongoing,...